To the full analysis
Buyback calculator for Carl Zeiss Meditec
Carl Zeiss Meditec stock: key metrics
AFX.DECarl Zeiss Meditec had an operating margin of 10% and a return on invested capital (ROIC) of 6.1% in fiscal 2025.
Margins show how much of revenue is left over, returns on capital how hard the invested money works.
Daily figure as of 13 Nov 2026
Margins
- Gross margin
- Operating margin
- Net margin
Figures as a table
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| 2006 | 47.0% | 12.3% | 6.8% |
| 2007 | 51.9% | 12.4% | 8.7% |
| 2008 | 50.6% | 11.4% | 9.4% |
| 2009 | 50.4% | 11.9% | 8.6% |
| 2010 | 53.0% | 12.8% | 8.8% |
| 2011 | 54.7% | 13.6% | 8.8% |
| 2012 | 53.5% | 14.3% | 8.3% |
| 2013 | 53.8% | 14.6% | 10.2% |
| 2014 | 53.7% | 13.3% | 8.2% |
| 2015 | 51.9% | 12.6% | 6.0% |
| 2016 | 53.2% | 14.2% | 9.0% |
| 2017 | 55.2% | 14.5% | 11.3% |
| 2018 | 55.5% | 15.4% | 9.9% |
| 2019 | 57.0% | 18.1% | 10.9% |
| 2020 | 55.8% | 0.0% | 9.2% |
| 2021 | 58.7% | 22.7% | 14.3% |
| 2022 | 59.3% | 20.9% | 15.4% |
| 2023 | 57.7% | 16.7% | 13.9% |
| 2024 | 52.7% | 9.4% | 8.7% |
| 2025 | 52.8% | 10.0% | 6.3% |
Returns on capital
- ROE
- ROIC
- ROA
Figures as a table
| Year | ROE | ROIC | ROA |
|---|---|---|---|
| 2006 | 12.0% | 17.8% | 6.9% |
| 2007 | 10.5% | 19.2% | 7.1% |
| 2008 | 11.5% | 16.1% | 7.9% |
| 2009 | 10.6% | 15.6% | 7.3% |
| 2010 | 10.4% | 18.8% | 7.1% |
| 2011 | 11.2% | 23.1% | 7.7% |
| 2012 | 11.0% | 17.5% | 7.5% |
| 2013 | 13.2% | 13.4% | 9.4% |
| 2014 | 10.5% | 11.1% | 7.2% |
| 2015 | 8.3% | 10.8% | 5.5% |
| 2016 | 12.3% | 13.2% | 7.9% |
| 2017 | 11.1% | 11.9% | 8.3% |
| 2018 | 9.8% | 10.9% | 7.6% |
| 2019 | 11.4% | 13.4% | 7.9% |
| 2020 | 8.5% | 0.0% | 6.1% |
| 2021 | 14.2% | 15.5% | 9.9% |
| 2022 | 14.6% | 14.2% | 10.4% |
| 2023 | 13.4% | 10.5% | 9.6% |
| 2024 | 8.8% | 5.7% | 5.3% |
| 2025 | 6.7% | 6.1% | 4.1% |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 30 Sep 2025
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 12 Nov 2026 ($1 = €0.9024)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 3 Oct 2025)
- Valuation signal Fairly valued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.